Ovarian function during use of a levonorgestrel-releasing IUD

References

1. • Nilsson C-G.
   • Allonen H.
   • Diaz H.
   • Luukkainen T.
   Two years experience with two levonorgestrel-releasing uterine devices and one copper-releasing intrauterine device.
   Fertil. Steril. 1983; 39: 187
   • Google Scholar
2. • Nilsson C-G.
   • Luukkainen T.
   • Diaz H.
   • Allonen H.
   Intrauterine contraception with levonorgestrel: A comparative randomized clinical performance study.
   Lancet. 1981; 1: 557
   • Google Scholar
3. • Sivin I.
   • Alvarez F.
   • Diaz J.
   • Diaz S.
   • Mahgoub S.
   • Coutinho E.M.
   • Brache V
   • Diaz M.
   • Faundes A.
   • Pavez M.
   • Mattos C.
   • Stern J.
   Intrauterine contraception with copper and with levonorgestrel. A randomized study of the TCu 380 Ag and levonorgestrel 20 mcg/day devices.
   Contraception. 1984; 30: 443
   • Google Scholar
4. • Nilsson C-G.
   • Lähteenmaki P.
   • Luukkainen T.
   Ovarian function in amenorrhoeic and menstruating users of a levonorgestrel-releasing intrauterine device.
   Fertil. Steril. 1984; 41: 52
   • Google Scholar
5. • Ratsula K.
   • Toivonen J.
   • Lähteenmaki P.
   • Luukkainen T.
   Plasma levonorgestrel levels and ovarian function during use of a levonorgestrel-releasing intracervical contraceptive device.
   Contraception. 1989; 39: 195
   • Google Scholar
6. • Nilsson C-G.
   Comparative quantitation of menstrual blood loss with a d-norgestrel-releasing IUD and Nova T copper device.
   Contraception. 1977; 15: 379
   • Google Scholar
7. • Nilsson C-G.
   • Lähteenmäki P.
   • Robertson D.
   • Luukkainen T.
   Plasma concentration of levonorgestrel as a function of the release rate of levonorgestrel from medicated intrauterine devices.
   Acta Endocrinol. (Copenh.). 1980; 93: 380
   • Google Scholar
8. • Weiner E.
   • Johansson E.D.B.
   Plasma levels of d-norgestrel, estradiol and progesterone during treatment with Silastic implants containing d-norgestrel.
   Contraception. 1976; 14: 81
   • Google Scholar
9. • Rosner W.
   A simplified method for the quantitative determination of testosterone-oestradiol binding globulin activity in human plasma.
   J. Clin. Endocrinol. Metab. 1972; 34: 983
   • Google Scholar
10. • Odlind V.
    • Elamsson K.
    • Englund D.
    • Victor A
    • Johansson E.D.B.
    Effects of estradiol on sex hormone binding globulin.
    Acta Endocrinol. 1982; 101: 248
    • Google Scholar
11. • Edqvist L-E.
    • Johansson E.D.B.
    Radioimmunoassay of oestrone and oestradiol in human and bovine peripheral plasma.
    Acta Endocrinol. (Copenh). 1972; 71: 716
    • Google Scholar
12. • Lindberg B-S.
    • Lindberg P.
    • Martinsson K.
    • Johansson E.D.B.
    Radioimmunological methods for the estimation of oestrone, oestradiol 17-beta and oestriol in pregnancy plasma.
    Acta Obstet. Gynecol. Scan. Suppl. 1974; 32: 5
    • Google Scholar
13. • Thorneycroft I.H.
    • Stone S.C.
    Radioimmunoassay of serum progesterone on women receiving oral contraceptive steroids.
    Contraception. 1972; 5: 129
    • Google Scholar
14. • Bosu W.T.K.
    • Edqvist L-R
    • Lindberg P.
    • Martinsson F.
    • Johansson E.D.B.
    The effects of various doses of lynestrenol on the plasma levels of oestrogens and progesterone during the menstrual cycle in the rhesus monkey.
    Contraception. 1976; 13: 677
    • Google Scholar
15. • Hackelöer B-J.
    • Fleming R.
    • Robinson H-P.
    • Adam A.H.
    • Coutts J.R.T.
    Correlation of ultrasonic and endocrinologic assessment of human follicular development.
    Am. J. Obstet. Gynecol. 1979; 135: 122
    • Google Scholar
16. • Belsey M.
    2nd ed. Laboratory Manual for Examination of Human Semen and Semen-Cervical Mucus Interaction. WHO, Geneva, Press Concern, Singapore1980
    • Google Scholar
17. • Landgren B.M.
    • Diczfalusy E.
    Hormonal effects of the 300 mcg norethisterone (NET) minipill. 1. Daily steroid levels in 43 subjects during a pretreatment cycle and during the second month of NET administration.
    Contraception. 1980; 21: 87
    • Google Scholar
18. • Tayob Y.
    • Adams J.
    • Jacob H.S.
    • Guillebaud J.
    Ultrasound demonstration of increased frequency of functional ovarian cysts in women using progestogen-only oral contraception.
    Br. J. Obstet. Gynecol. 1985; 92: 1003
    • Google Scholar
19. • Liukkonen S.
    • Koskimies A-I.
    • Tenhunen A
    • Ylostalo P.
    Diagnosis of luteinized unruptured follicle (LUF) syndrome by ultrasound.
    Fertil. Steril. 1984; 41: 26
    • Google Scholar
20. • Daly D.C.
    • Soto-Albors C.
    • Walters C.
    • Ying Y.
    • Riddick D.H.
    Ultrasonographic assessment of luteinized unruptured follicle syndrome in unexplained infertility.
    Fertil. Steril. 1985; 43: 62
    • Google Scholar
21. • Daly D.C.
    Treatment validation of ultrasound-defined abnormal follicular dynamics as a cause of infertility.
    Fertil. Steril. 1979; 51: 51
    • Google Scholar
22. • Ying Y.
    • Daly D.C.
    • Randolph J.F.
    • Soto-Albors C.E.
    • Maier D.B.
    • Schmidt C.L.
    • Riddick D.H.
    Ultrasonographic monitoring of follicular growth for luteal phase defects.
    Fertil. Steril. 1987; 48: 433
    • Google Scholar
23. • Daly D.C.
    • Reuter S.
    • Mastroianni J.
    Follicle size by ultrasound versus cervical mucus quality: normal and abnormal patterns in spontaneous cycles.
    Fertil. Steril. 1989; 51: 598
    • Google Scholar
24. • Olsson S-E.
    Contraception with subdermal implant releasing levonorgestrel. A clinical and pharmacological study.
    Acta Obst. Gynecol. Scand. Supplement 124. 1987;
    • Google Scholar

25. Olsson, S-E., Bakos, O., Lindgren, P-G., Odlind, V., Wide, L.: Ovarian function during use of subdermal implants releasing low doses of levonorgestrel. Submitted for publication in Contraception.

    • Google Scholar
26. • Robinson G.E.
    • Bounds W.
    • Kubba A.A.
    • Adams J.
    • Guillebaud J.
    Functional ovarian cysts associated with levonorgestrel- releasing intrauterine device.
    Brit. J. Family Planning. 1989; 14: 131
    • Google Scholar
27. • Geisthövel F.
    • Skubsch U.
    • Zabel G.
    • Schillinger H.
    • Breckwoldt M.
    Ultrasonographic and hormonal studies in physiologic and insufficient menstrual cycles.
    Fertil. Steril. 1983; 39: 277
    • Google Scholar
28. • Brache V.
    • Faundes A.
    • Johansson E.D.B.
    • Alvarez F.
    Anovulation, inadequate luteal phase and poor sperm penetration in cervical mucus during prolonged use of Norplant implants.
    Contraception. 1985; 31: 261
    • Google Scholar
29. • Alvarez F.
    • Brache V.
    • Tejada A.
    • Faundes A.
    Abnormal endocrine profile among women with confirmed or presumed ovulation during long-term Norplant use.
    Contraception. 1986; 33: 114
    • Google Scholar
30. • Eisser M.K.
    • Sawers R.S.
    • Docker M.F.
    • Lynch S.S.
    • Newton R.J.
    Characters and incidence of dysfunctional ovulation patterns detected by ultrasound.
    Fertil. Steril. 1987; 47: 603
    • Google Scholar
31. • Polan M.L.
    • Totore M.
    • Caldwell B.V.
    • Dellaney A.H.
    • Hesseltine F.I.P.
    • Rose N.
    Abnormal ovarian cycles as diagnosed by ultrasound and serum estradiol levels.
    Fertil Steril. 1982; 37: 342
    • Google Scholar
32. • Croxatto H.D.
    • Diaz S.
    • Pavez M.
    • Croxatto H.B.
    Histopathology of the endometrium during continuous use of levonorgestrel.
    in: Zatuchni G.L. Goldsmith A. Shelton J.D. Sciarra J.J. Long-acting Contraceptive Delivery Systems. Harper & Row, Philadelphia1984: 290
    • Google Scholar
33. • Martinez-Manatou J.
    • Azuar R.
    Endometrial morphology in women exposed to uterine systems releasing progesterone.
    Am. J. Obstet. Gynecol. 1975; 125: 175
    • Google Scholar